New aspects in the histological diagnosis of breast carcinoma.
The wide use of mammographic screening and breast conservation surgery, as well as the introduction of a variety of new morphological and immunohistological assessment methods, has markedly changed the practice of breast histopathology. These changes have led to the emergence of new macroscopic and microscopic interpretation demands and difficulties. It is hoped that in the future the role played by diagnostic histopathology in the management of breast cancer will continue to be refined, so that it can provide more detailed information about individual tumors that will help in deciding the most likely approach to obtain the best treatment results.
Shousha
S
S
Department of Histopathology, Charing Cross and Westminister Medical School and Hammersmith Hospitals NHS Trust, London, United Kingdom.
D001706:Biopsy / Q000379:methods; D001940:Breast / Q000473:pathology; D001943:Breast Neoplasms / Q000378:metabolism / Q000473:pathology*; D002278:Carcinoma in Situ / Q000473:pathology; D018270:Carcinoma, Ductal, Breast / Q000473:pathology; D018275:Carcinoma, Lobular / Q000473:pathology; D005260:Female; D018226:Fibroadenoma / Q000473:pathology; D005348:Fibrocystic Breast Disease / Q000473:pathology; D006801:Humans; D018300:Papilloma, Intraductal / Q000473:pathology; D018719:Erb-b2 Receptor Tyrosine Kinases / Q000378:metabolism; D011960:Receptors, Estrogen / Q000378:metabolism; D011980:Receptors, Progesterone / Q000378:metabolism; D016159:Tumor Suppressor Protein p53 / Q000378:metabolism
D018719:Erb-b2 Receptor Tyrosine Kinases; D011960:Receptors, Estrogen; D011980:Receptors, Progesterone; D016159:Tumor Suppressor Protein p53